Sentence examples for A minimal reduction of from inspiring English sources

A minimal reduction of c-fos LI in comparison to the control group could be observed in the caudal TNC for this dose (19.3 ± 2, p = 0.24), whereas no effect could be observed in more rostral parts of the TNC (8.9 ± 3.6, p = 0.99; n = 7).

A minimal reduction of 0.6 points in DAS28 is necessary for a moderate response, according to the European League Against Rheumatism response criteria [ 16].

To provide even a minimal reduction of greenhouse-gas emissions over a gasoline-engine vehicle, the diesel has to deliver considerably better fuel economy.

A refined set-up was devised by Gustafsson et al. (2014) which allowed the measurement of the lateral force component (the component that strives to separate the tools and increase the clearance), in addition to the force in the shearing direction, with a minimal reduction of lateral stiffness.

Low therapeutic doses of CGs result in a minimal reduction of the Na+/K+ ATPase activity and raise intracellular sodium levels.

With his consent, after oral prophylaxis, a minimal reduction of the talon cusp was carried out using a diamond bur in a high-speed water-cooled handpiece.

Noticeably, a minimal reduction in plasma levels of cardiac Tn-I was achieved by neutralization of KC in either adult or old mice.

A decrease in the amount of lesions in primary leaves was observed in virus samples that received 0.36 J/cm2 and 0.72 J/cm2 UV irradiation, but both showed only a minimal reduction in the number of lesions in secondary leaves (Figure 1, Table 1).

At 48 hours, VT2OcKO crypt architecture appeared slightly reduced compared to controls with a minimal reduction in the number of crypt cells (supplementary material Table S1).

In both, THC and CBD groups we found a minimal reduction in the number of BrdU-labeled type-1/2a cells, i.e. Nestin-GFP-positive, Doublecortin (DCX -negative cells, but a significant reDCX -negativee level of the type-2b cells (Nestin-GFP-positive, DCX-positive; THC vs. CTR: 502 ± 83 vs. 748 ± 78; n = 5; p = 0.028; Cbutvs. CTR: 507 ± 62 vs. 748 ± 78; n = 5; p = 0.032; Fig. 2B).

In another economic analysis study, CTTA-based strategies for selection of chemotherapy for patients with advanced NSCLC produced cost savings of £485 to £966 per patient, with a minimal reduction in quality-adjusted survival of 0.01 0.02 quality-adjusted life years, indicating a net monetary benefit of £264 to £544 per patient.